Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies.
In: ENP Newswire, 2021-07-23
Zeitungsartikel
Zugriff:
Titel: |
Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies.
|
---|---|
Zeitschrift: | ENP Newswire, 2021-07-23 |
Veröffentlichung: | 2021 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|